Current understanding of individual genetic characteristics is improving the ability to treat cardiovascular disorders.

 

Cardiovascular disease remains the number one cause of death in the United States and will likely become the number one cause of death globally. MyGenetx also offers genetic testing to help identify risks related to cardiovascular disease.

 

CARDIO GENETICS

KIF6, 9p21, 4q25

SINGLE GENE:

Haptoglobin Genotyping

This is proprietary to MyGenetx and identifies those at increased risk of cardiovascular disease and is especially relevant to diabetics.

APOE

DVT/THROMBOPHILIA

MTHFR, FACTOR II, FACTOR V

Identifies patients with unexplained DVT who would benefit from extended of lifelong anticoagulation.

 

PHARMACOGENETICS  "The right drug. The right dose. The first time."

Clopidogrel CYP2C19 FDA BLACK BOX WARNING

Beta Blockers CYP2D6

Anticoagulant Panel VKORC1, CYP2C9

Drug-to-Gene Interaction